Keyphrases
Bladder Cancer
100%
Urinary Markers
100%
Cancer-specific Survival
22%
Urinary Tumor Marker
22%
Early Detection
11%
Patient Characteristics
11%
Mortality Risk
11%
Surveillance Epidemiology
11%
Cancer Mortality
11%
Young Age
11%
Cox Proportional Hazards
11%
Fluorescence in Situ Hybridization
11%
Chi-square Test
11%
Logistic Regression Model
11%
Kaplan-Meier
11%
Overall Mortality
11%
Female Gender
11%
Medicare Database
11%
Multivariable Logistic Regression
11%
Cox Proportional Hazard Analysis
11%
Urine Cytology
11%
Charlson Score
11%
Nuclear Matrix Protein 22 (NMP22)
11%
UroVysion
11%
Oncological Outcomes
11%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Cancer Specific Survival
100%
Tumor Marker
100%
Chi-Square Testing
50%
Fluorescence in Situ Hybridization
50%
NMP22
50%
Medicine and Dentistry
Urinary System
100%
Bladder Cancer
100%
Prevalence
100%
Tumor Marker
18%
Cancer Specific Survival
18%
Malignant Neoplasm
9%
Medicare
9%
Fluorescence in Situ Hybridization
9%
Logistic Regression Analysis
9%
Proportional Hazards Model
9%
Chi Square Test
9%
Surveillance, Epidemiology, and End Results
9%
Urine Cytology
9%
NMP22
9%